Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.
Last updated on
About Variant Bio
Founded
2018Employees
11-50Funding / Mkt. Cap
$130MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
SeattleState
WashingtonCountry
United StatesVariant Bio
Find your buyer within Variant Bio